Positive press! SK3 Group and Alternative Energ
Post# of 36728
SK3 Group and Alternative Energy Partners Expand Medical-Marijuana Delivery in California
[ACCESSWIRE]
Medical Marijuana to Go
SK3 Group Inc. (OTC PINK: SKTO) and its partner A lternative Energy Partners (OTCQB: AEGY), doing business as PharmaJanes,™ announced Feb 10 that their e-commerce order servicing platform has expanded its delivery service area to include an additional 35 zip codes in California.
PharmaJanes™ facilitates enrollment of medical marijuana patients in its exclusive network of dispensaries by processing and verifying patients' applications in accordance with California state law requirements.
PharmaJanes™ then routes the orders to its exclusive non-profit collectives, which then process and deliver the orders to patients. Upon verification and completion of the application process, patients have access to all medical cannabis products available on the PharmaJanes™ menu for ordering and delivery. PharmaJanes™ features products produced by master growers, and products licensed by SK3 Group to its wholesale managed collectives.
This is just the latest bit of good news for the Miami-Fla. – based company that provides consulting services for California marijuana growers. On Feb. 14 the company announced that SK3 Group’s subsidiary has brought to market a cannabis-based supplement that will be sold by various stores in California.
Cannabis-Based Supplement to Soon Hit Shelves
According to SK3 Group’s release, the supplement, which is called Dharmanol™, was developed by David Hoye and Dr. Charles Apel of Berkeley Bio-Organic Research Laboratories. It contains less than .03% THC, less than many hemp-based health products that are sold at stores such as Costco and Walgreens, the release added.
But it contains 10 mg. of the non-psychoactive phyto-cannabinoids that are present in hemp/cannabis, and are thought to contribute to the myriad of mechanisms that many university-level scientific studies have shown to be responsible for the healing power of medical marijuana, according to SK3 Group.
Dharmanol™ tablets will be available soon in California through an online delivery service and select medicinal marijuana dispensaries.
Pretty Solid Track Record
While you have to take most announcements from penny stocks involved in medical marijuana industry with a healthy dose of skepticism, Sk3 Group’s past financial record makes it an exception to this rule. As with all new product rollouts you must not be overly optimistic, but at least this company know how to make a profit.
Its third-quarter 2013 results were decent, according to its SEC filing:
- current assets: $22.7 million
- total assets: $23.7 million
- cash: $129 thousand
- total current liabilities: $2.3 million
- revenue: $17.5 million
- net income: $3.2 million
On Feb. 24, SKTO’s share price closed at 3 cents, unchanged from its closing price of 3 cents the previous day, on stock volume of 9,928,701shares .
http://www.baystreet.ca/viewarticle.aspx?id=412287